Understanding Farydak

Farydak is the first histone deacetylase (HDAC) inhibitor approved for use in treating myeloma. Farydak is taken in capsule form in combination with Velcade® (bortezomib) and dexamethasone. by patients who have already been treated with Vel¬cade and an immunomodulatory drug.
Purchase this product
FREE